Monday 29th July 2024 |
Text too small? |
Infratil Limited's 30 June 2024 independent valuation update is attached.
As noted in the attached, CDC, Longroad, Galileo, Mint, Qscan and RetireAustralia values reflect the midpoint of the 30 June independent valuations. CDC’s key valuation methodologies and assumptions were presented as part the NZX valuation announcement on 4 July 2024.
Key valuation methodologies and assumptions underpinning the remaining independent valuations are summarised in the attached and remain consistent with the 31 March 2024 valuations [1], except for Longroad (refer below), and an update for the inclusion of storage for Galileo.
The decrease in the Longroad independent valuation is largely attributable to an increase in discount rates outweighing minor positive updates to operating forecasts.
Any enquiries should be directed to:
Mark Flesher, Investor Relations, Infratil Limited
info@infratil.com
[1] 1. Valuation methodologies and assumptions for 31 March 2024 included here: https://api.nzx.com/public/announcement/431367/attachment/418814/431367-418814.pdf
No comments yet
Kiwi Property launches Green Bond offer
TEM - Transaction in Own Shares
December 2nd Morning Report
MWE - Intention to De-list from the NZX Main Board
KMD Brands announces Release of Climate-Related Disclosure
Rua Bioscience expands product range in New Zealand
SPG - HY25 Interim Results
PaySauce FY25 Half Year Result and Interim Report
Synlait releases Integrated Climate Report
KORELLA MINE ADVANTAGED BY COMPLETION OF MAJOR ROAD RESEAL